NIH, NINR, and AHRQ Funding Opportunity Announcements
| Dates and Deadlines | Title | Summary Information |
|---|---|---|
|
Open Date: Sept. 10, 2021 Expires: Feb. 14, 2024 |
This Funding Opportunity Announcement (FOA) will support pragmatic trials within Stage IV of the NIH Stage Model to improve dementia care across multiple dementia care settings that will: (1) be designed to address practical comparative questions faced by Alzheimer’s disease (AD) and AD-related dementia (ADRD) patients, clinicians, and caregivers (both paid and unpaid); (2) include broad and diverse populations; and (3) be conducted in real-world settings with adequate sample size. These trials are intended to produce results that can be directly adopted by healthcare providers, patients, or caregivers for rapid dissemination and implementation. Successful applications will: (1) improve quality of care of persons with dementia; (2) improve quality of life for persons with dementia and their informal caregivers; (3) deliver more patient-focused, cost-effective care across multiple settings; and/or (4) reduce disparities in dementia care. This FOA will support Stage I or Stage III pilot research to test the feasibility of implementing and integrating interventions (R61 phase) that, if successful, can transition to an R33 phase (Stage IV) for implementation of large pragmatic trials. The transition from the R61 to the R33 phase of the award will be administratively reviewed and determined by successful completion of the go/no-go criteria that are specified for the R61 phase. |
|
|
Open Date: Sept. 10, 2021 Expires: Feb. 14, 2024 |
PAR-21-307: Dementia Care and Caregiver Support Intervention Research (R01 Clinical Trial Required) |
This Funding Opportunity Announcement (FOA) solicits mechanism-focused dementia care and caregiver support intervention development research at Stages I through V of the NIH Stage Model to address the care needs and promote the health, function, and well-being of persons with Alzheimer’s disease (AD) and Alzheimer’s disease-related dementias (ADRD) and of those providing their care. The NIH Stage Model offers a framework to: (1) support development of efficacious interventions that are defined by their principles; and (2) ensure that these efficacious interventions can be administered in the community or in health systems with fidelity to the intervention’s principles. This includes the development, testing, and validation of scalable training materials and procedures so that these interventions can be delivered with fidelity in community settings or health systems. Settings can include the home, community, or formal care settings, such as nursing homes, assisted living facilities, nursing and rehabilitation centers, hospitals, adult day care, and specialized hospice settings. The overarching purpose of this FOA is to help to lay the groundwork for real-world implementation of AD/ADRD care and caregiving interventions. The principle-based interventions under development may target behavioral, psychological, interpersonal, social, or institutional processes and may be designed for use at the individual, family, dyad, group, community, or health-systems level. Applications may propose mechanism-focused intervention research for individuals living with dementia or for individuals or systems providing care for people at any stage of AD/ADRD. Applications proposing the development of interventions that address the principles underlying the care needs and challenges for individuals from diverse racial, ethnic, and socioeconomic backgrounds are strongly encouraged. Applications that involve interdisciplinary expertise and translational expertise (e.g., basic behavioral, social, psychological, or neurobiological science expertise relevant to hypothesized intervention mechanisms; expertise in the AD/ADRD service delivery system; and clinical psychological science expertise in areas outside of aging or AD/ADRD, but potentially relevant to AD/ADRD caregiver research, etc.) are also strongly encouraged. Applications may propose to create, modify, and test AD/ADRD care and caregiver support interventions based upon hypothesized mechanisms of action and are encouraged to incorporate a test of essential components or mechanisms of change using an appropriate methodological approach. |
|
Posted Date: August 2, 2018
This Special Emphasis Notice will expire on September 30, 2021. |
Special Emphasis Notice (SEN): AHRQ Announces Interest in Health Services Research to Address the Opioids Crisis NOT-HS-18-015 |
The Agency for Healthcare Research and Quality (AHRQ) is interested in receiving health services research grant applications to advance our nation's understanding of the opioids crisis and provide solutions for addressing it. The Agency encourages research teams to submit applications in response to this emphasis using AHRQ’s standing R18, R03, and R01 funding mechanisms (PA-18-793, PA-18-794, PA-18-795). AHRQ also is interested in receiving career development awards (PA-16-223 and PA-17-232) that propose developing generalizable health service research skills through projects related to the opioids crisis. Additionally, AHRQ has interest in receiving dissertation award grant proposals that relate to the opioid crisis (PA-18-765). https://grants.nih.gov/grants/guide/notice-files/NOT-HS-18-015.html |
|
Posted Date: Dec 21, 2018 Standard dates apply by 5:00 PM local time of applicant organization This FOA will expire on Jan 8, 2022 |
End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses R21 Clinical Trial Optional: PAR-19-153 R01 Clinical Trial Optional: PAR-19-136 |
The purpose of this funding opportunity announcement (FOA) is to foster research on the unique perspectives, needs, wishes, and decision-making processes of adolescents and young adults (AYA; defined by the World Health Organization and the Centers for Disease Control and Prevention as youth between 12 – 24 years of age) with serious, advanced illnesses; and research focused on specific end-of-life/palliative care (EOLPC) models that support the physical, psychological, spiritual, and social needs of AYA with serious illness, their families and caregivers. To access the application and additional information, please visit: R21:https://grants.nih.gov/grants/guide/pa-files/PAR-19-153.html R01:https://grants.nih.gov/grants/guide/pa-files/PAR-19-136.html |
|
Posted Date: Nov 7, 2018 Standard dates apply, by 5:00 PM local time of applicant organization This FOA will expire on Jan 8, 2022. |
Strategies to Provide Culturally Tailored Palliative and End-of-Life Care for Seriously Ill American Indian and Alaska Native Individuals R21 Clinical Trial Optional: PAR-19-058 R01 Clinical Trial Optional: PAR-19-057 |
The purpose of this funding opportunity announcement (FOA) is to encourage research that will improve and increase the use of evidence-based interventions in end-of-life and palliative care (EOLPC) for American Indian/Alaska Native (AI/AN) individuals with advanced illness and their families and communities. To access the application and additional information, please visit: R21:https://grants.nih.gov/grants/guide/pa-files/PAR-19-058.html R01:https://grants.nih.gov/grants/guide/pa-files/PAR-19-057.html |
|
Posted Date: Nov 7, 2018 Standard dates apply, by 5:00 PM local time of applicant organization. Letter of Intent due 30 days prior to the application due date This FOA will expire on Jan 8, 2022. |
NINR Clinical Trial Planning Grant R34 Clinical Trial Required: PAR-19-060 |
The purpose of this Funding Opportunity Announcement (FOA) is to provide time and support for the applicant to develop and finalize plans for the design and execution of investigator-initiated clinical trials that are highly relevant to the NINR mission. Activities supported by this planning grant must include feasibility and pilot studies that inform the intervention viability and/or the trial design. To access the application and additional information, please visit: https://grants.nih.gov/grants/guide/pa-files/PAR-19-060.html |
|
Posted Date: Oct 31, 2018 Standard dates apply, by 5:00 PM local time of applicant organization This FOA will expire on Jan 8, 2022. |
End-of-Life and Palliative Care Approaches to Advanced Signs and Symptoms R21 Clinical Trial Optional: PAR-19-044 R01 Clinical Trial Optional: PAR-19-045 |
The purpose of this funding opportunity announcement (FOA) is to stimulate research to examine the multi-dimensional foundations, experiences, and management of complex, advanced signs and symptoms at the end of life. To access the application and additional information, please visit: R21: https://grants.nih.gov/grants/guide/pa-files/PAR-19-044.html R01: https://grants.nih.gov/grants/guide/pa-files/PAR-19-045.html |
Other Funding and Training Opportunities
| Dates and Deadlines | Title | Summary Information |
|---|---|---|
|
Rolling deadline
|
Palliative Care and Aging Research Training (T32) Opportunity |
Funded by a Ruth Kirschstein National Research Service Award NRSA T32 from the National Institute on Aging (NIA), this Program builds on the significant Palliative Care expertise and research opportunities within the University of Colorado. Participants become members of the community of scholars at the University of Colorado and are provided with the full array of resources available within the Department of Medicine and the Colorado Clinical & Translational Sciences Institute (CCTSI). More information about T32 opportunities at Colorado University Palliative Care Post-Doctoral |
|
Application Due Date: February 1st of desired start year Candidates will be selected on a rolling basis each year until each of the two new slots per year are filled. |
Weill Cornell Medicine Post-Doctoral Training Program in Behavioral Geriatrics (T32) |
This 2-year Postdoctoral Training Program in Behavioral Geriatrics develops independent investigators capable of conducting patient-oriented research to improve the quality of life and quality of care of older adults. The Program is co-led by Cary Reid, MD, PhD, Director of the Translational Research Institute on Pain in Later Life and Holly G. Prigerson, PhD, Director of the Center for Research on End-of-Life Care both based in the Department of Medicine, Division of Geriatrics and Palliative Medicine at Weill Cornell Medicine. Applications are accepted from both MD and PhD postdoctoral trainees (2/year) seeking careers at the intersection of biomedical and innovative social/behavioral approaches to improve care and care outcomes in older adults. Please see the links below for more information:
|
| Applications are accepted on a rolling basis for a variety of potential start dates |
Cambia Palliative Care Center of Excellence Palliative Care Research Fellowship Program |
Fellowships will be 1-3 years in duration. Trainees must have an interest in palliative care research related to heart, lung or blood disease. For more details and information about the Palliative Care Research Fellowship, please visit http://www.uwpalliativecarecenter.com |